Guiyang Xintian Pharmaceutical Co Ltd Strategic Asset Allocation Index
Guiyang Xintian Pharmaceutical Co Ltd strategic asset allocation index. Guiyang Xintian Pharmaceutical Co Ltd (002873) has a Strategic Asset Allocation Index of 54.5% as of September 2023. Strategic assets (PP&E of CN¥651.18 Million plus long-term investments of CN¥-) total CN¥651.18 Million, measured against net assets of CN¥1.20 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Guiyang Xintian Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guiyang Xintian Pharmaceutical Co Ltd (2015–2021)
Strategic asset allocation index of Guiyang Xintian Pharmaceutical Co Ltd from 2015 to 2021. This chart shows how Guiyang Xintian Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2015 to 2021. As of September 2023, the index stands at 54.5%, representing strategic assets of CN¥651.18 Million against net assets of CN¥1.20 Billion CNY. Check 002873 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Guiyang Xintian Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2015–2021)
Guiyang Xintian Pharmaceutical Co Ltd strategic asset allocation index by year from 2015 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Guiyang Xintian Pharmaceutical Co Ltd from 2015 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guiyang Xintian Pharmaceutical Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 52.1% | CN¥463.94 Million | CN¥463.94 Million | CN¥- | CN¥890.44 Million | ▲ +6.1 pp |
| 2020 | 46.0% | CN¥381.09 Million | CN¥381.09 Million | CN¥- | CN¥828.30 Million | ▼ -4.3 pp |
| 2019 | 50.3% | CN¥356.57 Million | CN¥356.57 Million | CN¥- | CN¥708.76 Million | ▲ +12.4 pp |
| 2018 | 37.9% | CN¥250.56 Million | CN¥250.56 Million | CN¥- | CN¥660.59 Million | ▼ -2.0 pp |
| 2017 | 39.9% | CN¥248.19 Million | CN¥248.19 Million | CN¥- | CN¥622.11 Million | ▼ -17.3 pp |
| 2016 | 57.2% | CN¥159.83 Million | CN¥159.83 Million | CN¥- | CN¥279.21 Million | ▼ -16.2 pp |
| 2015 | 73.4% | CN¥166.17 Million | CN¥166.17 Million | CN¥- | CN¥226.31 Million | — |